Tag
Amanta Healthcare Limited
11 articles
Amanta Healthcare concluded FY26 with robust financial performance, demonstrating a 5% revenue increase to ₹288 crore and a significant 42% jump in profit after tax to ₹15 crore. Improved operational efficiency, cost controls, and lower finance costs contributed to a healthy 6% rise in EBITDA to ₹63 crore and maintained margins at 22%. The company’s strategic focus on expanding high-margin SteriPort and SVP product capacities, alongside debt reduction and the commissioning of a solar plant to reduce costs, positions it favorably for continued growth in both domestic and export markets. Investors can anticipate further margin expansion and increased profitability as Amanta Healthcare continues to scale its operations and diversify its product portfolio.
Amanta Healthcare Submits Q4 FY26 Earnings Call Recording
Amanta Healthcare Ltd submitted audio recording of Q4 FY26 earnings conference call to BSE and NSE.
Recording is available on company website for investor access as per regulatory requirement.
Submiss
Amanta Healthcare Q4 & FY26 Results Announcement
Amanta Healthcare reported FY26 revenue of ₹288 crore, a 5% YoY increase, with PAT surging 42% YoY to ₹15 crore.
Q4FY26 revenue grew 7% YoY to ₹77 crore, while PAT increased 28% YoY to ₹5.5 crore due
Amanta Healthcare FY26 PAT Jumps 42% to ₹15 Crore
Amanta Healthcare reported FY26 revenue of ₹288 crore, a 5% YoY increase, with PAT surging 42% to ₹15 crore.
EBITDA for the year stood at ₹63 crore, a 6% YoY rise, with margins improving to 22% from c
Amanta Healthcare FY26 Net Profit Rises 43.6% YoY
Amanta Healthcare reported a 43.6% YoY increase in standalone net profit to ₹1,582.35 lakhs for FY26.
The company completed its IPO in Q2 FY25, raising ₹12,600 lakhs, with ₹5,246.75 lakhs remaining un
Amanta Healthcare Q4 FY26 Earnings Call Schedule
Amanta Healthcare will host an earnings conference call on May 19, 2026, to discuss Q4 and full-year FY26 financial performance.
Management participants include MD Bhavesh Patel, CFO Paras Mehta, and
Amanta Healthcare Q4 FY26 Earnings Call Schedule
Amanta Healthcare schedules Q4 and FY26 earnings conference call for May 19, 2026 at 3:30 PM IST.
Call will discuss financial performance and business updates for quarter and year ended March 31, 2026
Amanta Healthcare Board Meeting for FY26 Results
Amanta Healthcare board meeting scheduled for May 19, 2026 to approve audited financial results for Q4 and FY ending March 31, 2026.
Trading window closed from April 1, 2026 will reopen on May 22, 202
Amanta Healthcare Promoter Bhavesh Patel Share Acquisition Clarification
Amanta Healthcare clarifies credit of 15,500 shares to promoter Bhavesh Patel's demat account on April 17, 2026.
Revised promoter holding increases to 63,26,544 shares (16.29%) from previous 63,11,044
Amanta Healthcare Clarifies Promoter Share Acquisition Discrepancy
Amanta Healthcare submits a clarification to BSE and NSE regarding a prior disclosure about promoter share acquisition.
The company corrects that only 13,300 shares were credited to promoter Bhavesh P
Amanta Healthcare Promoter Buys 28,800 Shares
Amanta Healthcare discloses Form C under SEBI Insider Trading Regulations for open market purchase by promoter.
Shri Bhavesh Patel, Promoter, CMD, acquired 28,800 equity shares on March 27 and March 3
Amanta Healthcare Insider Share Purchase by Director's Relative
Ms. Dympal Jain, immediate relative of Director Shri Nitin Jain, purchased 15,675 equity shares of Amanta Healthcare Limited via open market between March 19–24, 2026.
The total transaction value was